MiNK Therapeutics, Inc.
INKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $2 | $3 | $5 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $15 | $2 | $4 | $5 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $15 | $2 | $4 | $6 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $3 |
| Short-Term Debt | $6 | $6 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $4 | $4 | $4 |
| Total Curr. Liab. | $13 | $13 | $12 | $7 |
| LT Debt | $0 | $0 | $0 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $15 | $15 | $14 | $13 |
| Total NC Liab. | $15 | $15 | $14 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $28 | $28 | $26 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$154 | -$151 | -$147 | -$144 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $141 | $127 | $126 | $125 |
| Total Equity | -$14 | -$25 | -$22 | -$20 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $15 | $2 | $4 | $6 |
| Net Debt | -$9 | $4 | $2 | $0 |